Jazz Pharmaceuticals PLC at Cantor Fitzgerald Global Healthcare Conference Transcript

Sep 26, 2023 / 04:25PM GMT
Charles Duncan -

Next presenting company. I'm Charles Duncan. I'm a Biotech Analyst with Cantor. And it's a pleasure to introduce Jazz Pharmaceuticals, who's going to present at the Cantor 2023 Global Healthcare Conference. Jazz Pharmaceuticals is a company I've known for a long time. But I only recently had an opportunity to take over coverage. And so it's an exciting time for this company that I've previously known as a neuro innovator, but it clearly has a very interesting oncology pipeline as well.

So it's a pleasure to introduce Bruce Cozadd the company's Chairman and CEO, Bruce. Nice to see you. Thanks for coming. Robert Iannone, the company's Global Head of R&D, Rob, nice to see you. And Kim Sablich, the company's EVP and GM. So sorry for the delay. I had to run upstairs and grab a tylenol, but with that, we'll have Bruce give us an overview on Jazz, and then I'll pepper him with a few questions. Bob?

Bruce C. Cozadd - Jazz Pharmaceuticals plc - Co-Founder, Chairman & CEO

Awesome. And Charles, thanks for the introduction. I'm glad to be here at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot